Ginseng Efficacy in the Clinical Improvement of Brucellosis

  • Aliasghar Farazi * Infectious Disease Research Center, School of Medicine, Arak University of Medical Sciences, Arak, Iran
  • Masoomeh Sofian Infectious Disease Research Center, School of Medicine, Arak University of Medical Sciences, Arak, Iran
  • Hosein Sarmadian Infectious Disease Research Center, School of Medicine, Arak University of Medical Sciences, Arak, Iran
Keywords: Brucellosis, Efficacy, Ginseng, Supplement


Background and Aim: Brucellosis, which is considered as one of the most prevalent zoonoses worldwide, is a major public health problem in several developing countries. The aim of the present study was to conduct an objective evaluation of ginseng’s potential to improve the symptoms of brucellosis.Materials and Methods: In a randomized controlled single-blind study, 62 patients with acute brucellosis after taking informed consent were randomly categorized into two therapeutic groups, namely the ginseng group and the control group. All the patients were examined to check their clinical response at the days 0, 3, 7, 14. The patients were followed for recurrence until 9 month after the initiation of treatment. The required data were collected and analyzed with SPSS software (ver. 18).Results: Sixty-two patients participated in the study. The most prevalent findings were fever (90.2%), sweating (77.2%), fatigue and malaise symptoms (73.9%), arthritis and arthralgia (70.79%). The efficacy of ginseng compared to the control group to improve symptoms after one week was as follows: fever (P value = 0.083), sweating (P value = 0.19), fatigue and malaise (P value = 0.021), arthritis, and arthralgia (P value = 0.013). The relapse rate did not differ significantly between the two groups in nine-month follow up (P value = 0.693).Conclusion: Ginseng might be efficient in the improvement of clinical signs and symptoms in patients and also in the rise of patients’ compliance with treatment. Moreover, it has no serious side effects.


Das S, Kuila P, Dutta D, Chakrabarty U, Chatterjee D. Comparison of serological tests and PCR for diagnosis of human brucellosis suffering from fever. Asian J Pharm Clin Res. 2017;10(5):109-11.

Sen A, Banerjee P, Dutta D, Pal M, Ray A, Das S. Brucellar uveitis in eastern India. Asian J Pharm Clin Res. 2016;9(6):196-200.

Pappas G, Akritidis N, Bosilkovski M, and Tsianos E. Brucellosis. N Engl J Med. 2005;352(22):2325-36.

Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91-9.

Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010;36:S8-11.

de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015;185:1505-17.

Lee JJ, Kim DH, Kim DG, Lee HJ, Min W, Rhee MH, et al. Phellinus baumii extract influences pathogenesis of Brucella abortus in phagocyte by disrupting the phagocytic and intracellular trafficking pathway. J Appl Microbiol. 2013;114:329-38.

Byeon SE, Lee J, Kim JH, Yang WS, Kwak YS, Kim SY, et al. Molecular mechanism of macrophage activation by red ginseng acidic polysaccharide from Korean red ginseng. Mediators Inflamm. 2012;732860.

Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng c.a Meyer. Acta Pharmacol Sin. 2008;29:1109-18.

Yoo DG, Kim MC, Park MK, Park KM, Quan FS, Song JM, et al. Protective effect of ginseng polysaccharides on influenza viral infection. PLoS One. 2012;7:e33678.

Reyes AW, Simborio HL, Hop HT, Arayan LT, Min WG, Lee HJ, et al. Inhibitory effect of red ginseng acidic polysaccharide from Korean red ginseng on phagocytic activity and intracellular replication of Brucella abortus in RAW 264.7 cells. J Vet Sci. 2016;17(3):315–21.

Huy TX, Reyes AW, Hop HT, Arayan LT, Min W, Lee HJ, et al. Intracellular Trafficking Modulation by Ginsenoside Rg3 Inhibits Brucella abortus Uptake and Intracellular Survival within RAW 264.7 Cells. J Microbiol Biotechnol. 2017;27(3):616-23.

Reyes AWB, Hop HT, Arayan LT, Huy TXN, Park SJ, Kim KD, et al. The host immune enhancing agent Korean red ginseng oil successfully attenuates Brucella abortus infection in a murine model. J Ethnopharmacol. 2017;198:5-14.

Ranjbar M, Keramat F, Mamani M, Kia AR, Khalilian FO, Hashemi SH, et al. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis. 2007;11(2):152-6.

Kang S., Min H., Ginseng, the ‘Immunity boost’: the effects of Panax ginseng on immune system. J. Ginseng Res.2012;36:354-68.

Neta A.V., Mol J.P.S., Xavier M.N., Paixão T.A., Lage A.P., Santos R.L., Pathogenesis of bovine brucellosis. Vet. J. 2010;184;146-55.

Huynh KK, Eskelinen E, Scott CC, Malevanets A, Saftig P, Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 2007;26:313-24.

Park EH, Yum J, Ku KB, Kim HM, Kang YM, Kim JC, et al. Red ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus. J. Ginseng Res. 2014;38;40-6.

Xavier MN, Winter MG, Spees AM, Nguyen K, Atluri VL, Silva TM, et al. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLoS Pathog. 2013;9:e1003454.

Lee NH, Son CG. Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng. J Acupunct Meridian Stud. 2011;4:85-97.

Shim JY, Kim MH, Kim HD, Ahn JY, Yun YS, Song JY. Protective action of the immunomodulator ginsan against carbon tetrachloride-induced liver injury via control of oxidative stress and the inflammatory response. Toxicol Appl Pharmacol. 2010;242:318-25.

Kim E, Cameron M, Lovera J, Schaben L, Bourdette D, Whitham R. American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study. Mult Scler. 2011;17:1523-6.

Barton DL, Liu H, Dakhil SR, Sloan JA, Nichols CR, McGinn TW, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105:1230-8.

Etemadifar M, Sayahi F, Abtahi SH, et al. Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study. Int J Neurosci. 2013;123:480-6.

Kim HG, Cho JH, Yoo SR, Shemshaki H, Dorooshi GA, Goodarzi M, et al. Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial. PLoS One. 2013;8:e61271.

Liang MT, Podolka TD, Chuang WJ. Panax notoginseng supplementation enhances physical performance during endurance exercise. J Strength Cond Res. 2005;19:108-14.

Kulaputana O, Thanakomsirichot S, Anomasiri W. Ginseng supplementation does not change lactate threshold and physical performances in physically active Thai men. J Med Assoc Thai. 2007;90:1172-9.

Yoon SJ, Kim KH, Kim CJ, Park HC, Kang KH, Kim MJ, et al. Effects of red ginseng supplementation on aerobic anaerobic performance, central and peripheral fatigue. J Ginseng Res. 2008;32:210-9.

Clinical Trial